- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dyslipidemia Associated With Type II Diabetes Mellitus in Poland
Total 817 results
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Thailand, United Kingdom, Malaysia, New Zealand, Taiwan, Turkey, Canada, Mexico, Israel, India, Argentina, Brazil, Russian Federation, Australia, Korea, Republic of, Italy, Philippines, Colombia, Poland, Chile, Finland and more
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Medical University of South CarolinaWeight Watchers InternationalCompletedObesity | Overweight | Type 2 DiabetesUnited States
-
TikoMed ABTerminatedDiabetes Mellitus, Type 1Sweden, Norway, Netherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Croatia, Germany, Turkey, Slovakia, Bulgaria, Romania, Algeria, Czechia, Ukraine
-
SanofiCompletedType 2 Diabetes MellitusGermany, Spain, United States, Canada, Czechia, Hungary, Mexico, Russian Federation
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Serbia, Poland, Hungary, South Africa, Ukraine, Romania, Slovakia, Czech Republic
-
ActivX Biosciences, Inc.Kyorin Pharmaceutical Co.,LtdCompletedType 2 DiabetesUnited States, Poland, Argentina, Russian Federation, Czech Republic, South Africa, Guatemala
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
Helmholtz Zentrum MünchenUniversitaire Ziekenhuizen KU Leuven; Technical University of Munich; Medical... and other collaboratorsRecruitingDiabetes Mellitus, Type 1Belgium, Germany, Poland, Sweden, United Kingdom
-
SanofiTerminated
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Lexicon PharmaceuticalsSanofiCompletedType 1 Diabetes MellitusIsrael, Italy, Spain, Bulgaria, Hungary, Poland, Slovakia, United Kingdom, Austria, Belgium, France, Germany, Lithuania, Netherlands, Romania, Sweden, Switzerland
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus, Type 1Austria, Germany, Poland, United Kingdom
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
GlaxoSmithKlineDuke Clinical Research InstituteCompletedDiabetes MellitusUnited States, Argentina, Germany, Poland, Russian Federation, Spain, Taiwan, Czechia, Hungary, Italy, Ukraine, Belgium, Netherlands, South Africa, Sweden, Thailand, Korea, Republic of, Mexico, Bulgaria, Hong Kong, Peru, Philippines, Gree... and more
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
-
Intarcia TherapeuticsCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Canada, Poland, South Africa, Slovakia
-
TakedaCompletedType 2 DiabetesUnited States, Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Slovakia, Czech Republic
-
Halozyme TherapeuticsCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, Italy, United States, Germany, United Kingdom, Russian Federation, Canada, Poland, Puerto Rico, Macedonia, The Former Yugoslav Republic of
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, United States, Estonia, Mexico, South Africa, Taiwan, Russian Federation, Canada, Slovakia, United Kingdom, Malaysia, Thailand, Australia, Hungary, Bulgaria, Brazil, Germany, Lithuania, Denmark, Romania, Ukraine, Poland, India, Israe... and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes | Type 1 DiabetesUnited States, Taiwan, Japan, Poland, Argentina, Slovakia, Puerto Rico